Clinical Report: Efficacy and Safety of Nebulized Chinese Herbal Remedies
Overview
This meta-analytical review evaluates the efficacy and safety of nebulized Chinese herbal medicine as an adjunctive therapy for pediatric pneumonia.
Background
Pneumonia is a leading cause of morbidity and mortality in children, particularly those under five years old. Traditional management often involves antibiotics, which may not be routinely administered to preschool-aged children due to the prevalence of viral pathogens. The exploration of adjunctive treatments, such as nebulized Chinese herbal medicine, is essential to enhance clinical outcomes and reduce antibiotic use.
Data Highlights
Outcome
Effect Size
Confidence Interval
p-value
Total clinical effective rate
Odds Ratio = 3.24
(2.24, 4.68)
< 0.001
Resolution time of respiratory symptoms
SMD = -1.10
(-1.56, -0.64)
< 0.001
Fever resolution time
SMD = -1.01
(-1.59, -0.43)
0.0006
Hospital stay duration
SMD = -1.06
(-1.38, -0.73)
< 0.001
Key Findings
Seventeen RCTs involving 1,764 patients were included in the meta-analysis.
Nebulized Chinese herbal medicine significantly improved the total clinical effective rate compared to conventional therapy alone.
Combination therapy shortened the resolution time of respiratory symptoms and fever.
The duration of hospital stay was significantly reduced with the addition of nebulized herbal medicine.
Methodological limitations in the included studies suggest the need for further validation in larger trials.
Clinical Implications
Clinicians should consider the findings while being mindful of the need for further research.
Conclusion
Further rigorous studies are necessary to validate these findings.
